Babies should get recently approved drug for RSV, CDC says
This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. On Thursday, Aug. 3, 2023, a panel of outside advisers to the Centers for Disease Control and Prevention recommended that babies get the drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year.
(AstraZeneca via AP, File)
Infants should get a recently approved drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, U.S. health officials said Thursday...
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
